KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Change in Inventory (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Change in Inventory for 8 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 2.62% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, up 1009.84% year-over-year, with the annual reading at $2.1 million for FY2025, 1009.84% up from the prior year.
  • Change in Inventory hit $1.6 million in Q4 2025 for Castle Biosciences, up from $307000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $2.2 million in Q4 2023 to a low of -$1.4 million in Q3 2024.
  • Historically, Change in Inventory has averaged $382500.0 across 5 years, with a median of $318000.0 in 2022.
  • Biggest five-year swings in Change in Inventory: soared 1991.67% in 2021 and later plummeted 333.0% in 2025.
  • Year by year, Change in Inventory stood at -$355000.0 in 2021, then skyrocketed by 150.14% to $178000.0 in 2022, then skyrocketed by 1120.79% to $2.2 million in 2023, then decreased by 28.07% to $1.6 million in 2024, then grew by 2.62% to $1.6 million in 2025.
  • Business Quant data shows Change in Inventory for CSTL at $1.6 million in Q4 2025, $307000.0 in Q3 2025, and $1.5 million in Q2 2025.